Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1034/j.1399-0012.1999.t01-1-130103.x http://scihub22266oqcxt.onion/10.1034/j.1399-0012.1999.t01-1-130103.x 10081630!ä!10081630 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10081630&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Transplant 1999 ; 13 (1 Pt 1): 17-24 Nephropedia Template TP {{tp|p=10081630|t=1999. Human parvovirus B19 infection in organ transplant recipients |pdf=|usr=}}{{10081630}} gab.com Text Human parvovirus B19 infection in organ transplant recipients JO: Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=10081630 #FOAvip We report a 61-yr-old kidney transplant recipient with human Parvovirus B19 (HPV B19) infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow aspiration revealed severe erythroid hypoplasia with giant and dystrophic proerythroblasts. Bone marrow cells were positive for HPV B19 DNA detected by polymerase chain reaction (PCR). Pancytopenia resolved shortly after administration of intravenous immunoglobulins. Nineteen cases of HPV B19 infection in organ transplant recipients have been so far reported in the literature. Immunocompromised patients should be considered at risk from developing symptomatic HPV B19 infections. In such patients, specific anti-HPV B19 IgM and IgG antibodies may be absent or transient and therefore their negativity cannot rule out the diagnosis of HPV B19 infestation. Bone marrow smear morphological findings may suggest the diagnosis but testing for viral DNA by PCR is mandatory. Patients may spontaneously recover. However, since specific anti-viral therapy is not currently available, intravenous immunoglobulin administration appears to be the more efficacious treatment. Twit Text FOAVip Human parvovirus B19 infection in organ transplant recipients ????Clin Transplant http://www.kidney.de/pget.php?&tw=1&pmid=10081630 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=10081630 #FOAvip English Wikipedia <ref>{{Cite pmid|10081630}}</ref> Human parvovirus B19 infection in organ transplant recipients #MMPMID10081630 Marchand S; Tchernia G; Hiesse C; Tertian G; Cartron J; Kriaa F; Boubenider S; Goupy C; Lecointe D; Charpentier B Clin Transplant 1999[Feb]; 13 (1 Pt 1): 17-24 PMID10081630show ga We report a 61-yr-old kidney transplant recipient with human Parvovirus B19 (HPV B19) infection presenting as a severe pancytopenia 1 month after transplantation. Bone marrow aspiration revealed severe erythroid hypoplasia with giant and dystrophic proerythroblasts. Bone marrow cells were positive for HPV B19 DNA detected by polymerase chain reaction (PCR). Pancytopenia resolved shortly after administration of intravenous immunoglobulins. Nineteen cases of HPV B19 infection in organ transplant recipients have been so far reported in the literature. Immunocompromised patients should be considered at risk from developing symptomatic HPV B19 infections. In such patients, specific anti-HPV B19 IgM and IgG antibodies may be absent or transient and therefore their negativity cannot rule out the diagnosis of HPV B19 infestation. Bone marrow smear morphological findings may suggest the diagnosis but testing for viral DNA by PCR is mandatory. Patients may spontaneously recover. However, since specific anti-viral therapy is not currently available, intravenous immunoglobulin administration appears to be the more efficacious treatment. |*Immunocompromised Host[MESH] |*Kidney Transplantation[MESH] |*Parvovirus B19, Human/isolation & purification[MESH] |DNA, Viral/analysis[MESH] |Humans[MESH] |Immunoglobulin G/analysis[MESH] |Immunoglobulin M/analysis[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Neutrophils/immunology[MESH] |Parvoviridae Infections/*diagnosis/drug therapy/etiology[MESH]Human parvovirus B19 infection in organ transplant recipients (epmc).pdf DeepDyve Pubget Overpricing